Skip to content

IDEAYA Biosciences, Inc. IDYA Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Tango Therapeutics logo
Tango TherapeuticsTNGX
-$45.85M-14.6%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$184.77M-501%
Immunome logo
ImmunomeIMNM
-$53.84M-29.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$73.46M+3.4%
Nuvation Bio logo
Nuvation BioNUVB
$3.91M+107%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$50.66M-145%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
IDEAYA Biosciences, Inc. (IDYA) reported comprehensive income (loss), net of tax, attributable to parent of -$101.3M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 41.9% year-over-year, from -$71.41M to -$101.3M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 22.1% compound annual growth rate (CAGR), from -$50.48M to -$112.24M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric measures the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on investments. It provides a more holistic view of financial performance by including gains and losses that bypass the traditional income statement. Investors use this to assess the total impact of all economic events on the company's net worth during a specific period.